We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bed Bath & Beyond (BBBY) to Post Q3 Earnings: What's in Store?
Read MoreHide Full Article
Bed Bath & Beyond Inc. is slated to release third-quarter fiscal 2020 results on Jan 7, 2021. This leading specialty retailer is likely to deliver revenue and earnings growth in the to-be-reported quarter. The Zacks Consensus Estimate for the company’s fiscal third-quarter earnings is pegged at 21 cents, whereas it reported a loss of 38 cents in the year-ago quarter. The consensus estimate has moved up 10.5% in the past 30 days.
The consensus estimate for fiscal third-quarter sales is pegged at $2.77 billion, indicating a 0.3% increase from the prior-year quarter’s reported number.
In the last reported quarter, the company delivered an earnings surprise of 394.1%. However, its bottom line substantially missed estimates by 232.4%, on average, in the trailing four quarters.
Bed Bath & Beyond is one of the few retailers that have been benefiting from consumers’ shift to online shopping amid the pandemic. The company has been witnessing robust sales trends in the digital platform since fourth-quarter fiscal 2019. Omni-channel services such as Buy-Online-Pick-Up-In-Store (BOPIS) and Curbside Pickup have been contributing to digital sales growth. Additionally, strong digital sales aided comparable sales (comps) growth in the second quarter of fiscal 2020.
In the last reported quarter’s earnings call, management noted that the momentum in comparable sales (comps) as well as store and digital sales continued in September. The persistence of positive trends in comps and digital business is likely to have bolstered the company’s top line in the fiscal third quarter.
Additionally, the company’s efforts to expedite the delivery and supply-chain network through the conversion of Bed Bath & Beyond and buybuy BABY stores in the United States and Canada into regional fulfillment centers have been paying off. Also, it partnered with Shipt to launch a same-day delivery service in its namesake and buybuy baby stores, which is likely to have aided sales during the holiday season. Gains from these actions are also likely to get reflected in the company’s robust digital sales results for the to-be-reported quarter.
Also, stringent cost-cutting actions and strong financial position contributed to bottom-line growth in the fiscal third quarter.
Zacks Model
Our proven model predicts an earnings beat for Bed Bath & Beyond this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Bed Bath & Beyond currently has a Zacks Rank #3 and an Earnings ESP of +32.28%.
Other Stocks Poised to Beat Earnings Estimates
Here are some other companies that you may want to consider as our model shows that these also have the right combination of elements to post an earnings beat:
Constellation Brands, Inc. (STZ - Free Report) currently has an Earnings ESP of +0.25% and a Zacks Rank #3.
Kimberly-Clark Corporation (KMB - Free Report) presently has an Earnings ESP of +3.77% and a Zacks Rank #3.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
Bed Bath & Beyond (BBBY) to Post Q3 Earnings: What's in Store?
Bed Bath & Beyond Inc. is slated to release third-quarter fiscal 2020 results on Jan 7, 2021. This leading specialty retailer is likely to deliver revenue and earnings growth in the to-be-reported quarter. The Zacks Consensus Estimate for the company’s fiscal third-quarter earnings is pegged at 21 cents, whereas it reported a loss of 38 cents in the year-ago quarter. The consensus estimate has moved up 10.5% in the past 30 days.
The consensus estimate for fiscal third-quarter sales is pegged at $2.77 billion, indicating a 0.3% increase from the prior-year quarter’s reported number.
In the last reported quarter, the company delivered an earnings surprise of 394.1%. However, its bottom line substantially missed estimates by 232.4%, on average, in the trailing four quarters.
Bed Bath & Beyond Inc. Price and EPS Surprise
Bed Bath & Beyond Inc. price-eps-surprise | Bed Bath & Beyond Inc. Quote
Key Points to Note
Bed Bath & Beyond is one of the few retailers that have been benefiting from consumers’ shift to online shopping amid the pandemic. The company has been witnessing robust sales trends in the digital platform since fourth-quarter fiscal 2019. Omni-channel services such as Buy-Online-Pick-Up-In-Store (BOPIS) and Curbside Pickup have been contributing to digital sales growth. Additionally, strong digital sales aided comparable sales (comps) growth in the second quarter of fiscal 2020.
In the last reported quarter’s earnings call, management noted that the momentum in comparable sales (comps) as well as store and digital sales continued in September. The persistence of positive trends in comps and digital business is likely to have bolstered the company’s top line in the fiscal third quarter.
Additionally, the company’s efforts to expedite the delivery and supply-chain network through the conversion of Bed Bath & Beyond and buybuy BABY stores in the United States and Canada into regional fulfillment centers have been paying off. Also, it partnered with Shipt to launch a same-day delivery service in its namesake and buybuy baby stores, which is likely to have aided sales during the holiday season. Gains from these actions are also likely to get reflected in the company’s robust digital sales results for the to-be-reported quarter.
Also, stringent cost-cutting actions and strong financial position contributed to bottom-line growth in the fiscal third quarter.
Zacks Model
Our proven model predicts an earnings beat for Bed Bath & Beyond this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Bed Bath & Beyond currently has a Zacks Rank #3 and an Earnings ESP of +32.28%.
Other Stocks Poised to Beat Earnings Estimates
Here are some other companies that you may want to consider as our model shows that these also have the right combination of elements to post an earnings beat:
The Procter & Gamble Company (PG - Free Report) has an Earnings ESP of +1.67% and a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Constellation Brands, Inc. (STZ - Free Report) currently has an Earnings ESP of +0.25% and a Zacks Rank #3.
Kimberly-Clark Corporation (KMB - Free Report) presently has an Earnings ESP of +3.77% and a Zacks Rank #3.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>